Early Stage Venture Unlearn.AI Raises Series A of $3000000

About Unlearn.AI

Unlearn.AI develops a platform to accelerate clinical trials for Alzheimer’s Disease, Multiple Sclerosis, and other complex diseases.

Website: Learn more on Unlearn.AI’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – Unlearn.AI

Amount Raised	3000000 USD
Announced Date	2020-11-05
Equity Only Funding	Yes
Organization Location	San Francisco, California, United States, North America
Funding Status	Early Stage Venture
Number of Funding Rounds	2
Lead Investors
Number of Investors	3
Number of Partner Investors